Audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026
THYROCARE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Thyrocare Technologies reported strong FY2026 results with standalone revenue of Rs. 774.27 Crores, up 22% from Rs. 633.10 Crores in FY2025. Consolidated revenue stood at Rs. 829.04 Crores, growing 21% year-on-year. Standalone profit after tax (PAT) jumped 55% to Rs. 148.81 Crores from Rs. 95.78 Crores, while consolidated PAT increased 79% to Rs. 162.86 Crores. The auditors M S K A & Associates LLP issued an unmodified (clean) opinion on both standalone and consolidated results. Exceptional items of Rs. 5.97 Crores were recorded, including Rs. 4.01 Crores from new labour code implementation (gratuity changes) and Rs. 1.96 Crores from capital restructuring costs. The board recommended a dividend of Rs. 7 per share.
The company delivered robust double-digit revenue growth alongside even stronger profit growth, indicating improved operational efficiency. The clean audit opinion removes any concerns about financial reporting quality, which should boost investor confidence in the near term.